Daiken Medical Co., Ltd.

TSE:7775.T

500 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 988.6021,025.0251,151.337944.751,191.111,153.6721,362.4811,697.611,703.2081,601.0661,382.9591,252.3341,002.24915.287800.427621.414491.916
Depreciation & Amortization 216.148267.295314.423256.517253.178302.875250.979175.912183.573155.356188.96250.281302.34303.218241.804174.088161.058
Deferred Income Tax 0-354.623-221.4500000000000000
Stock Based Compensation 11.29513.5217.36800000000000000
Change In Working Capital 318.6442.163-147.291-248.843288.731-331.729-63.728-30.652-162.047-144.586-66.5878.608-178.52217.697-147.9-131.734-344.566
Accounts Receivables 48.991-99156138-132155-23.58359.428-112.025-183-207-6500000
Inventory 76.64929.839-122.625-248.458326.411-269.703-242.81-103.90566.89518.36-48.778133.308-249.294-78.987-22.758-3.307-150.487
Accounts Payables -50.405113.30846.181-8.74129.657-92.69176.582-10.259-5.67700000000
Other Working Capital 243.409-41.984-226.847-129.645-35.337-124.335179.08273.253-228.942-162.946-17.802-54.770.77296.684-125.142-128.427-194.079
Other Non Cash Items 389.16735.77529.236-343.254-296.114-243.893-294.629-492.517-429.738-471.816-510.279-369.554-871.878-315.424-342.795-50.587-174.917
Operating Cash Flow 1,555.5989.1561,133.623609.171,436.905880.9251,255.1031,350.3531,294.9961,140.02995.061,211.669254.18920.778551.536613.181133.491
Investing Activities:
Investments In Property Plant And Equipment -168.803-199.049-203.216-312.047-169.162-207.16-637.573-612.111-1,314.883-380.679-163.557-115.324-255.795-244.184-239.258-182.538-370.032
Acquisitions Net 000.912-4.090000000000000
Purchases Of Investments 000-0.7330000000000000
Sales Maturities Of Investments 0000.87444.46707.9371.377007.13504.3030000
Other Investing Activites 0.036-11.4776.0674.09-36.069-1.6324.7966.752-1.317-2.436-0.9462.231-1.574-2.2-1.254-3.019-23.618
Investing Cash Flow -168.767-210.526-196.237-311.906-160.764-208.792-624.84-603.982-1,316.2-383.115-157.368-113.093-253.066-246.384-240.512-185.557-393.65
Financing Activities:
Debt Repayment -589.847-604.492-704.034-908.031-873.998-645.668-619.502-289.952-423.124-313.423-399.636-523.66-738.461-794.235-868.962-1,380.18-1,157.763
Common Stock Issued 000001,596.2613.55601,095.52524.5651.42650.4397.07530.5640832.2689.496
Common Stock Repurchased -0.0010000-999.993-7890-0.046-422.260-0.02-0.051570-0.1234001,200
Dividends Paid -573.955-565.32-574.296-574.884-546.127-773.338-809.372-480.359-479.781-367.52-499.632-170.139-161.433-123.048-79.696-48.102-37.395
Other Financing Activities -0.001388.805688.891990.894291.779-0.0011,632.72241.05-0.001492.477-0.802-200.4641,049.745-12.442630-17.472-0.001
Financing Cash Flow -1,163.804-781.007-589.439-492.021-1,128.346-822.739-581.596-729.261192.573-586.106-788.644-843.844156.875-329.161-318.781-213.49494.337
Other Information:
Effect Of Forex Changes On Cash 00-0.001000-0.00100.001-0.001-0.0010000-0.0010
Net Change In Cash 222.929-2.377347.946-194.757147.795-150.60648.66617.11171.37170.79849.047254.732157.989345.233-7.757214.129-165.822
Cash At End Of Period 2,739.1412,516.2122,518.5892,170.6432,365.42,217.6052,368.2112,319.5452,302.4352,131.0651,960.2671,911.221,656.4881,498.4991,153.2661,161.023946.894